After peritumoral injection, the prepared mU@OMVs is easily recognized and phagocytized by TAMs, resulting in efficient inhibition of the phosphorylation of MerTK in TAMs, and then the efferocytosis blockade of apoptotic cells and the secondary necrosis of tumor cells. The gene discussed is MERTK; the disease is neoplasm.